Literature DB >> 8866185

Quality assurance in the mycobacteriology laboratory. Quality control, quality improvement, and proficiency testing.

G L Woods1, J C Ridderhof.   

Abstract

In conclusion, the components of QA (QC, QI, and PT) in the mycobacteriology laboratory address not only the accuracy of testing but also provide a measure for the laboratory practices that are necessary to effectively diagnose and control tuberculosis in the community. Given the extremely important role of laboratory testing in the control of tuberculosis, providing rapid diagnosis and determination of susceptibility test results, laboratories should use the recommendations concerning turnaround times as either achievable goals or a measure of whether the laboratory should be performing mycobacteriology tests. We strongly urge laboratories to include their turnaround times for test results and the timeliness of reporting those results in their annual QA program.

Entities:  

Mesh:

Year:  1996        PMID: 8866185

Source DB:  PubMed          Journal:  Clin Lab Med        ISSN: 0272-2712            Impact factor:   1.935


  4 in total

1.  Proficiency testing of drug susceptibility results in the Canadian Network of Public Health TB laboratories.

Authors:  A Laszlo
Journal:  Can J Infect Dis       Date:  1996-11

2.  Clinical Evaluation of the Gen-Probe amplified mycobacterium tuberculosis direct test for rapid detection of Mycobacterium tuberculosis in select nonrespiratory specimens.

Authors:  G L Woods; J S Bergmann; N Williams-Bouyer
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

3.  Clinical evaluation of the enhanced Gen-Probe Amplified Mycobacterium Tuberculosis Direct Test for rapid diagnosis of tuberculosis in prison inmates.

Authors:  J S Bergmann; G Yuoh; G Fish; G L Woods
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

4.  Development and validation of external quality assessment panels for mycobacterial culture testing to diagnose tuberculosis in China.

Authors:  Jian Du; Wei Shu; Yuhong Liu; Yufeng Wang; Ying Zhan; Kexin Yu; Jingtao Gao; Liang Li; Yu Pang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-07-24       Impact factor: 3.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.